They further corroborated their studies by demonstrating that blockade of IL-1β signaling significantly decreases tumor angiogenesis in C57B16 IL-1β knockout mice compared to wild-type and IL-1α knockout mice [112], highlighting the importance of IL-1β in promoting angiogenesis in cancer cells [112,113]. This evidence concerns the gene IL1B and cancer.